In summary, our results indicate that the ERp57/STAT3/ILF3 feedback loop plays a key role in the oncogenesis of ccRCC and provides a potential therapeutic target for ccRCC treatment. This evidence concerns the gene PDIA3 and nonpapillary renal cell carcinoma.